Restart Life Sciences Q2 FY26 gross profit rises to C$130,699; revenue more than doubles to C$331,162 vs Q1 FY26

Reuters2026/09/03 10:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Restart Life posted Q2 2026 revenue of CAD 331,162, more than doubled from Q1 on Holy Crap Foods integration.
H1 2026 revenue was CAD 465,715, versus no revenue a year earlier following the Holy Crap acquisition on Feb. 26, 2026.
Q2 gross profit rose to CAD 130,699, with gross margin at 39.5%.
June Holy Crap revenue was about CAD 110,000 with roughly 35% gross margins, up 64.2% year over year.
Management cited U.S. entry via Amazon, a Walmart.ca listing, and a Caribbean pilot, while evaluating health and CPG M&A.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Restart Life Sciences Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609030600NEWSFILECNPR____20260903_312691_1) on September 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Restart Life Sciences Q2 FY26 gross profit rises to C$130,699; revenue more than doubles to C$331,162 vs Q1 FY26

You may also like

Crypto prices